Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 20 for Novartis AG�
Company Exchange Symbol Last price Quote change Market cap
Valeant Pharmaceuticals Intl Inc NYSE VRX 237.53 +4.26 (1.83%) 79.63B
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, ...
Novartis AG (ADR) NYSE NVS 103.85 -0.94 (-0.90%) 279.16B
Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and ...
Novartis AG VTX NOVN 98.10 +0.05 (0.05%) 263.31B
Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and ...
Valeant Pharmaceuticals Intl Inc TSE VRX 291.64 +6.41 (2.25%) 99.41B
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, ...
NOVARTIS AG BASL OTCMKTS NVSEF 104.60 0.00 (0.00%) 280.01B
Celgene Corporation NASDAQ CELG 116.09 -0.11 (-0.09%) 92.36B
Celgene Corporation is a global biopharmaceutical company primarily engaged in the discovery, development and commercialization of therapies designed to ...
VALEANT PHARMACEUT. INTL FRA BVF 211.00 +1.50 (0.72%)
NOVARTIS AG CEDEAR EACH REP 0.5 ADR BCBA NVS 600.00 0.00 (0.00%)
Valeant Pharma SWX VRX 197.60 0.00 (0.00%)
MorphoSys AG ETR MOR 68.59 +0.89 (1.31%) 1.80B
... development for diabetic nephropathy and fibrotic diseases, well as five programs in the discovery phase and two pre-development programs with Novartis.
MorphoSys AG FRA MOR 68.80 +1.30 (1.93%) 1.81B
... development for diabetic nephropathy and fibrotic diseases, well as five programs in the discovery phase and two pre-development programs with Novartis.
Morphosys Ag (ADR) OTCMKTS MPSYY 37.42 0.00 (0.00%) 1.98B
... development for diabetic nephropathy and fibrotic diseases, well as five programs in the discovery phase and two pre-development programs with Novartis.
MORPHOSYS AG OTCMKTS MPSYF 74.91 0.00 (0.00%) 1.98B
MORPHOSYS AG O.N. NEUE ETR MORN 17.48
MORPHOSYS AG O.N. NEUE FRA MORN 17.00
MORPHOSYS AG O.N. NEUE ETR MORA 0.0000
CELGENE CORP. DL-,01 FRA CG3 105.05 +0.42 (0.40%)
Celgene Corp SWX CELG 110.00 0.00 (0.00%)
MORPHOSYS AG O.N. NEUE FRA MORA 37.00
CELGENE CORP. DL-,01 ETR CG3 104.40 -0.50 (-0.48%)